David D. Wisnoski

3.4k total citations
26 papers, 1.7k citations indexed

About

David D. Wisnoski is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, David D. Wisnoski has authored 26 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Organic Chemistry and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in David D. Wisnoski's work include Receptor Mechanisms and Signaling (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Microwave-Assisted Synthesis and Applications (5 papers). David D. Wisnoski is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Microwave-Assisted Synthesis and Applications (5 papers). David D. Wisnoski collaborates with scholars based in United States and United Kingdom. David D. Wisnoski's co-authors include Craig W. Lindsley, William Leister, Zhijian Zhao, S. E. Wolkenberg, Yi Wang, Cyrille Sur, Wei Lemaire, P. Jeffrey Conn, Mark E. Duggan and David L. Williams and has published in prestigious journals such as Biochemistry, Annals of the New York Academy of Sciences and Journal of Medicinal Chemistry.

In The Last Decade

David D. Wisnoski

26 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David D. Wisnoski United States 17 805 789 565 92 81 26 1.7k
T. G. Murali Dhar United States 24 668 0.8× 1.1k 1.4× 400 0.7× 84 0.9× 47 0.6× 67 2.0k
Eric Vieira Switzerland 18 825 1.0× 430 0.5× 542 1.0× 47 0.5× 99 1.2× 25 1.4k
Stephen R. Fletcher United States 20 941 1.2× 640 0.8× 323 0.6× 182 2.0× 81 1.0× 38 1.8k
Trevor Howe United Kingdom 13 697 0.9× 308 0.4× 393 0.7× 67 0.7× 64 0.8× 24 1.2k
Derek C. Cole United States 21 1.1k 1.4× 908 1.2× 272 0.5× 182 2.0× 42 0.5× 39 1.9k
Wilma Quaglia Italy 26 1.2k 1.4× 580 0.7× 736 1.3× 152 1.7× 49 0.6× 122 1.9k
Günter Neef Germany 18 635 0.8× 472 0.6× 400 0.7× 79 0.9× 86 1.1× 71 1.4k
Andrew Pike United Kingdom 19 558 0.7× 917 1.2× 370 0.7× 55 0.6× 91 1.1× 26 1.8k
Kyle A. Emmitte United States 29 1.4k 1.7× 550 0.7× 1.0k 1.8× 185 2.0× 110 1.4× 68 2.2k
Jens‐Uwe Peters Switzerland 17 737 0.9× 328 0.4× 355 0.6× 204 2.2× 56 0.7× 38 1.3k

Countries citing papers authored by David D. Wisnoski

Since Specialization
Citations

This map shows the geographic impact of David D. Wisnoski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David D. Wisnoski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David D. Wisnoski more than expected).

Fields of papers citing papers by David D. Wisnoski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David D. Wisnoski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David D. Wisnoski. The network helps show where David D. Wisnoski may publish in the future.

Co-authorship network of co-authors of David D. Wisnoski

This figure shows the co-authorship network connecting the top 25 collaborators of David D. Wisnoski. A scholar is included among the top collaborators of David D. Wisnoski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David D. Wisnoski. David D. Wisnoski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Charnley, Adam K., M.A. Convery, Emma J. Jones, et al.. (2015). Crystal structures of human RIP2 kinase catalytic domain complexed with ATP-competitive inhibitors: Foundations for understanding inhibitor selectivity. Bioorganic & Medicinal Chemistry. 23(21). 7000–7006. 24 indexed citations
2.
Harris, Philip A., Rakesh Nagilla, Viera Kasparcova, et al.. (2015). Characterization of GSK′963: a structurally distinct, potent and selective inhibitor of RIP1 kinase. Cell Death Discovery. 1(1). 15009–15009. 115 indexed citations
3.
Guillon, Christophe, David D. Wisnoski, Ned D. Heindel, et al.. (2014). N<sup>ω</sup>-Nitro-N<sup>ω’</sup>-Substituted Guanidines: A Simple Class of Nitric Oxide Synthase Inhibitors. PubMed Central. 3(2). 48–58. 2 indexed citations
4.
Rubach, Jon K., Guanglei Cui, Jessica L. Schneck, et al.. (2012). The Amino-Acid Substituents of Dipeptide Substrates of Cathepsin C Can Determine the Rate-Limiting Steps of Catalysis. Biochemistry. 51(38). 7551–7568. 15 indexed citations
5.
Evans, Karen A., Barry G. Shearer, David D. Wisnoski, et al.. (2011). Phenoxyacetic acids as PPARδ partial agonists: Synthesis, optimization, and in vivo efficacy. Bioorganic & Medicinal Chemistry Letters. 21(8). 2345–2350. 8 indexed citations
6.
Evans, Karen A., David D. Wisnoski, Jian Jin, et al.. (2010). Synthesis and structure–activity relationships of a series of 3-aryl-4-isoxazolecarboxamides as a new class of TGR5 agonists. Bioorganic & Medicinal Chemistry Letters. 20(4). 1363–1367. 39 indexed citations
7.
Hamill, Terence G., Waisi Eng, Richard Lewis, et al.. (2010). The synthesis and preclinical evaluation in rhesus monkey of [18F]MK‐6577 and [11C]CMPyPB glycine transporter 1 positron emission tomography radiotracers. Synapse. 65(4). 261–270. 27 indexed citations
8.
Wolkenberg, S. E., Zhijian Zhao, David D. Wisnoski, et al.. (2009). Discovery of GlyT1 inhibitors with improved pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters. 19(5). 1492–1495. 15 indexed citations
9.
Shipe, William D., David D. Wisnoski, Zhijian Zhao, et al.. (2009). Parallel synthesis of N-biaryl quinolone carboxylic acids as selective M1 positive allosteric modulators. Bioorganic & Medicinal Chemistry Letters. 20(2). 531–536. 40 indexed citations
10.
Natarajan, S., David D. Wisnoski, James E. Thompson, Edward A. O’Neill, & Stephen J. O’Keefe. (2006). p38 MAP kinase inhibitors. Part 3: SAR on 3,4-dihydropyrimido[4,5-d]pyrimidin-2-ones and 3,4-dihydropyrido[4,3-d]pyrimidin-2-ones. Bioorganic & Medicinal Chemistry Letters. 16(16). 4400–4404. 7 indexed citations
11.
Wisnoski, David D., Julie A. O’Brien, Wei Lemaire, et al.. (2006). Challenges in the development of mGluR5 positive allosteric modulators: The discovery of CPPHA. Bioorganic & Medicinal Chemistry Letters. 17(5). 1386–1391. 58 indexed citations
12.
Kinney, Gene G., Julie A. O’Brien, Wei Lemaire, et al.. (2005). A Novel Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Has in Vivo Activity and Antipsychotic-Like Effects in Rat Behavioral Models. Journal of Pharmacology and Experimental Therapeutics. 313(1). 199–206. 229 indexed citations
13.
Wisnoski, David D., et al.. (2005). Acetonitrile/water gas‐phase reaction products observed by use of atmospheric pressure chemical ionization: adducts formed with sulfonamides. Rapid Communications in Mass Spectrometry. 19(5). 667–673. 6 indexed citations
14.
O’Brien, Julie A., Wei Lemaire, Marion Wittmann, et al.. (2004). A Novel Selective Allosteric Modulator Potentiates the Activity of Native Metabotropic Glutamate Receptor Subtype 5 in Rat Forebrain. Journal of Pharmacology and Experimental Therapeutics. 309(2). 568–577. 132 indexed citations
15.
Wolkenberg, S. E., David D. Wisnoski, William Leister, et al.. (2004). Efficient Synthesis of Imidazoles from Aldehydes and 1,2‐Diketones Using Microwave Irradiation.. ChemInform. 35(35). 3 indexed citations
16.
Zhao, Zhijian, David D. Wisnoski, S. E. Wolkenberg, et al.. (2004). General microwave-assisted protocols for the expedient synthesis of quinoxalines and heterocyclic pyrazines. Tetrahedron Letters. 45(25). 4873–4876. 193 indexed citations
17.
Williams, David L., Julie A. O’Brien, Wei Lemaire, et al.. (2003). Difference in mGluR5 Interaction between Positive Allosteric Modulators from Two Structural Classes. Annals of the New York Academy of Sciences. 1003(1). 481–484. 2 indexed citations
18.
19.
Natarajan, S., David D. Wisnoski, Suresh B. Singh, et al.. (2003). p38MAP kinase inhibitors. part 1: design and development of a new class of potent and highly selective inhibitors based on 3,4-dihydropyrido[3,2-d]pyrimidone scaffold. Bioorganic & Medicinal Chemistry Letters. 13(2). 273–276. 32 indexed citations
20.
McDonald, Chriss E., et al.. (2001). Cyclization of unsaturated amides with triflic anhydride and samarium diiodide. Tetrahedron Letters. 42(2). 163–166. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. G. Murali Dhar Breakdown of academic impact, for papers by Eric Vieira Breakdown of academic impact, for papers by Stephen R. Fletcher Breakdown of academic impact, for papers by Trevor Howe Breakdown of academic impact, for papers by Derek C. Cole Breakdown of academic impact, for papers by Wilma Quaglia Breakdown of academic impact, for papers by Günter Neef Breakdown of academic impact, for papers by Andrew Pike Breakdown of academic impact, for papers by Kyle A. Emmitte Breakdown of academic impact, for papers by Jens‐Uwe Peters
Rankless by CCL
2026